Insider Transactions in Q4 2021 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+43.68%
|
$0
$0.71 P/Share
|
|
Nov 30
2021
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
172,585
+31.33%
|
$0
$0.32 P/Share
|
|
Nov 15
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
479
-96.03%
|
$9,101
$19.34 P/Share
|
|
Nov 12
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,562
-94.7%
|
$162,678
$19.51 P/Share
|
|
Nov 11
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,276
-42.0%
|
$385,520
$20.13 P/Share
|
|
Nov 10
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,326
-15.45%
|
$234,194
$19.96 P/Share
|
|
Nov 09
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,576
-23.92%
|
$591,520
$20.12 P/Share
|
|
Nov 08
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,017
-11.38%
|
$180,340
$20.16 P/Share
|
|
Nov 05
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,042
-7.07%
|
$260,840
$20.16 P/Share
|
|
Nov 04
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,392
-7.42%
|
$140,448
$19.76 P/Share
|
|
Nov 03
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
26,184
-7.23%
|
$471,312
$18.75 P/Share
|
|
Nov 02
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,519
-12.22%
|
$297,823
$17.43 P/Share
|
|
Nov 01
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
469
-0.33%
|
$8,442
$18.02 P/Share
|
|
Oct 15
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,433
-0.49%
|
$25,794
$18.07 P/Share
|
|
Oct 14
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,749
-3.81%
|
$103,482
$18.18 P/Share
|
|
Oct 11
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,270
-0.83%
|
$22,860
$18.02 P/Share
|
|
Oct 08
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,902
-3.73%
|
$106,236
$18.15 P/Share
|
|
Oct 07
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,018
-7.6%
|
$234,324
$18.56 P/Share
|
|
Oct 06
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,108
-1.22%
|
$37,944
$18.03 P/Share
|
|
Oct 05
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,404
-3.02%
|
$97,272
$18.26 P/Share
|
|
Oct 04
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$1,800
$18.0 P/Share
|
|
Oct 01
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
274
-0.15%
|
$4,932
$18.0 P/Share
|